Global Aptamers Market, by Type (Nucleic Acid Aptamers (DNA-Based Aptamers, RNA-Based Aptamers and XNA-Based Aptamers) and Peptide Aptamers), by Application (Diagnostics, Therapeutics, and Research and Development), by End User (Biotechnology and Pharmaceutical Companies, Contract Research Organization, Academic and Research Institutions), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be US$  3626.13 million in 2019 and is expected to exhibit a CAGR of 18.5% over the forecast period (2019-2027).

The global aptamers market size is expected to witness significant growth during the forecast period, owing to increasing research and development activities by various biopharmaceutical companies and research institutes. For instance, in 2016, The Institute of Bioengineering and Nanotechnology (IBN) Singapore, invented an efficient DNA aptamers technology for detection and treatment of cancer and various infectious diseases such as dengue and malaria.

Furthermore, in April 2019, Aptamer Therapeutics Ltd, announced a partnership with Dan Wiseman and the Oglesby Leukemia Research Programme at the University of Manchester and Cancer Research UK for development of aptamers as therapeutic agent for treatment of Chronic Myelomonocytic Leukemia (CMML) and other myeloid malignancies.

In July 2019, University of Minnesota launched an exclusive aptamers technology for radiation therapy. It is used to treat brain tumor patients with the latest generation advanced radiosurgery technology. The radiosurgery works by focusing radiation beams from different angles to a small target.

Browse 35 Market Data Tables and 33 Figures spread through 185 Pages and in-depth TOC on "Global Aptamers Market, by Type (Nucleic Acid Aptamers (DNA-Based Aptamers, RNA-Based Aptamers and XNA-Based Aptamers) and Peptide Aptamers), by Application (Diagnostics, Therapeutics and Research and Development), by End User (Biotechnology and Pharmaceutical Companies, Contract Research Organization, Academic and Research Institutions), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2027"

To know the latest trends and insights related to global aptamers market, click the link below:

https://www.coherentmarketinsights.com/market-insight/aptamers-market-774

Continuous investments by biotechnological and pharmaceutical companies and introduction of next generation products are the major factors that are expected to boost growth of the aptamers market. The growing number of academic research laboratories that are investigating potential of aptamers, as well as the rising number of products under clinical investigation have increased the rate of market penetration and demand for aptamers across the globe.

Key Takeaways of the Global Aptamers Market:

  • The global aptamers market is expected to exhibit a CAGR of 18.5% over the forecast period (2019–2027), owing to increasing research and development activities by various biopharmaceutical companies and research institutes
  • Among type, the nucleic acid aptamers segment is expected to account for a major revenue share by 2027. Aptamers are useful in biotechnological and therapeutics application as they offer molecular recognition properties.
  • Major players operating in the global aptamers market include Elekta AB, Varian Medical Systems Inc., Huiheng Medical Inc., Cyber Medical Corporation Limited, Masep Infini Global Inc., ET Medical Group, Nordion Inc., Hokai and GE Healthcare.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner